Apex Healthcare Berhad (KLSE:AHEALTH)

Apex Healthcare Berhad Cash Flow Statement

Financials in millions MYR. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	65.46	76.54	397.99	100.97	59.42	56.02
Depreciation & Amortization	22.52	20.99	17.59	16.15	15.97	16.14
Other Amortization	0.78	0.78	0.48	0.31	0.37	0.31
Loss (Gain) From Sale of Assets	-0.05	-0.2	-0.28	-0.69	-0.18	-0.18
Asset Writedown & Restructuring Costs	0.21	0.2	0	0	0.07	0.02
Loss (Gain) on Equity Investments	14.42	9.78	-336.4	-29.57	-7.1	-8.66
Stock-Based Compensation	0.81	0.88	0.75	0.64	0.67	0.72
Provision & Write-off of Bad Debts	0.06	0.01	0.66	0.92	-0.04	0.86
Other Operating Activities	-1.19	-5.99	-1.04	0.93	2.47	-0.09
Change in Accounts Receivable	-18.95	1.71	-13.02	-19.21	-30.59	25.13
Change in Inventory	5.43	-5.17	-17.12	-15.6	-4.77	-6.15
Change in Accounts Payable	1.75	-30.53	15.58	17.22	25.54	-2.4
Change in Other Net Operating Assets	-	-	-	-	-	3.77
Operating Cash Flow	91.25	69	65.19	72.07	61.82	85.49
Operating Cash Flow Growth	76.98%	5.84%	-9.54%	16.59%	-27.69%	25.16%

Investing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Capital Expenditures	28.92	-27.97	-25.93	-30.32	-10.97	-15.83
Sale of Property, Plant & Equipment	0.11	0.32	0.35	0.78	0.18	0.29
Sale (Purchase) of Intangibles	-3	-3	-2.07	-1.61	-1.18	-0.03
Sale (Purchase) of Real Estate	-	-	-0.23	-2.28	-0.91	-
Investment in Securities	0.5	0.5	-4.83	-	-	-
Other Investing Activities	25.18	8.65	231.17	81.52	-1.94	-35.61
Investing Cash Flow	51.7	-21.5	198.45	48.1	-14.81	-51.17

Financing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Long-Term Debt Repaid	-	-8.54	-6.69	-6.64	-6.94	-4.13
Net Debt Issued (Repaid)	-59.2	-8.54	-6.69	-6.64	-6.94	-4.13
Issuance of Common Stock	2.26	2.92	2.62	2.11	1.59	3.57
Common Dividends Paid	-64.85	-61.2	-34.71	-28.64	-25.22	-17.54
Other Financing Activities	-2.07	-1.4	-0.56	-0.84	-0.6	-1.07
Financing Cash Flow	-145.5	-212.16	-48.91	-62.63	-31.17	-19.17

Net Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Foreign Exchange Rate Adjustments	-0.82	-3.45	1.07	3.11	1.39	-0.01
Net Cash Flow	-3.37	-168.1	215.81	60.65	17.23	15.14

Free Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Free Cash Flow	120.17	41.03	39.26	41.76	50.85	69.66
Free Cash Flow Growth	-	4.52%	-5.97%	-17.88%	-27.00%	29.40%
Free Cash Flow Margin	12.39%	4.27%	4.19%	4.76%	6.60%	9.97%
Free Cash Flow Per Share	0.17	0.06	0.06	0.06	0.07	0.10
Levered Free Cash Flow	96.51	20.15	30.46	24.45	39.22	59.31
Unlevered Free Cash Flow	97.78	21.03	30.81	24.93	39.76	60.02

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash Interest Paid	2.07	1.4	0.56	0.76	0.53	0.75
Cash Income Tax Paid	25	24.83	21.14	17.65	13.97	14.36
Change in Working Capital	-11.77	-33.99	-14.56	-17.6	-9.82	20.35

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 25, 2026

Data Sources Report a data error